{"id":14218,"date":"2023-10-30T19:45:42","date_gmt":"2023-10-30T19:45:42","guid":{"rendered":"https:\/\/dev.haugpartners.com\/?post_type=article&#038;p=14218"},"modified":"2024-09-26T09:05:39","modified_gmt":"2024-09-26T09:05:39","slug":"baxaltas-antibody-patent-held-invalid-under-amgens-enablement-standard-by-the-federal-circuit","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/baxaltas-antibody-patent-held-invalid-under-amgens-enablement-standard-by-the-federal-circuit\/","title":{"rendered":"Baxalta\u2019s Antibody Patent Held Invalid under Amgen\u2019s Enablement Standard by the Federal Circuit"},"featured_media":0,"template":"","categories":[98,101],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/14218"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=14218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=14218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}